Ecomectin 6 mg/g Premix for Medicated Feeding Stuff for Pigs

البلد: المملكة المتحدة

اللغة: الإنجليزية

المصدر: VMD (Veterinary Medicines Directorate)

العنصر النشط:

Ivermectin

متاح من:

Eco Animal Health Ltd

ATC رمز:

QP54AA01

INN (الاسم الدولي):

Ivermectin

الشكل الصيدلاني:

Premix for medicated feeding stuff

نوع الوصفة الطبية :

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

المجموعة العلاجية:

Pigs

المجال العلاجي:

Endectocide

الوضع إذن:

Authorized

تاريخ الترخيص:

2008-05-23

خصائص المنتج

Revised: June 2023
AN: 00322/2023
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Ecomectin 6 mg/g Premix for medicated feeding stuff for pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Ivermectin6 mg/g
EXCIPIENT(S):
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Premix for medicated feeding stuff
Yellow-brown, free-flowing granules
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Pigs
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of nematode or arthropod infections due to:
GASTROINTESTINAL ROUNDWORMS
_Ascaris suum_ (adults and L4)
_Hyostrongylus rubidus_ (adults and L4)
_Oesophagostomum_ spp. (adults and L4)
_Strongyloides ransomi _(adults)*
LUNGWORMS
_Metastrongylus_ spp. (adults)
LICE
_Haematopinus suis_
MANGE MITES
_Sarcoptes scabiei_ var. _suis_
*Given to pregnant sows before farrowing, it effectively controls
transmission via milk
of _S. ransomi _to piglets.
4.3
CONTRAINDICATIONS
Do not use for any other animal species as severe adverse reactions,
including
fatalities in dogs may occur.
Revised: June 2023
AN: 00322/2023
Page 2 of 6
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Exposure of treated pigs to infected animals, contaminated premises,
soil or pasture
may result in re-infestation and re-treatment may be necessary. Since
the effect of
ivermectin on mange mites is not immediate, avoid direct contact
between treated
and untreated pigs for at least one week after completion of
treatment. Because
louse eggs are unaffected by ivermectin and may take up to three weeks
to hatch, re-
treatment may be necessary.
Care should be taken to avoid the following practices because they
increase the risk
of development of resistance and could ultimately result in
ineffective therapy:
•
Too frequent and repeated use of anthelmintics from the same class,
over an
extended period of time.
•
Underdosing,
which
may
be
due
to
underestimation
of
body
weight,
misadministration of the product, or lack of calibration of the dos